ArticleEuropean journal of pediatrics2025
Burden and management of venous thromboembolism in children and adolescents (2004-2023): a Swiss nationwide epidemiological study.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study.The Lancet. Respiratory medicine · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidemiological data on venous thromboembolism (VTE) in children and adolescents is sparse and available primarily for the USA. In Europe, the burden and management of VTE have rarely been subjects of nationwide analyses.We conducted a nationwide, retrospective, patient-level analysis of the Swiss medical statistics an administrative data collection including 1961 hospitalizations (1653 incident events) with VTE aged 19 or younger between 2004 and 2023. We estimated the disease-specific incidence rate, in-hospital case fatality rates, length of stay (LOS), and related admission to the intensive care unit (ICU). Furthermore, we evaluated therapeutic procedures.The incidence rate of incident VTE-related hospitalizations was 4.9 (95%CI 4.7; 5.2) per 100,000 children and adolescents per year. The in-hospital case fatality rate was 4.0% (95%CI 3.2; 5.0); the median LOS was 8 (Q1-Q3 4-24) days. Systemic thrombolysis, catheter-directed treatment, and inferior vena cava filters were used in less than 15% of patients. Among patients receiving systemic thrombolysis, the in-hospital case fatality rate was 19.4% (95%CI 12.6; 28.5), whereas patients managed with catheter-directed treatment had a rate of 8.0% (95%CI 3.2; 18.8). 39.3% of patients were admitted to ICU. Age- and sex-specific differences in incidence rate, proportion of hospital admissions, and in-hospital case fatality rate were observed, particularly among infants aged < 1 year and adolescents aged 15-19 years.
conclusionVTE among children and adolescents is rare with age- and sex-specific differences in incidence. Patients who underwent advanced treatment strategies presented with a substantial risk of in-hospital death despite treatment, especially evident among patients aged 0-9 years. WHAT IS KNOWN: • Venous thromboembolism and in extension pulmonary embolism and deep vein thrombosis are rare diseases among children and adolescents. WHAT IS NEW: • We provided national estimates for measures of occurrence of venous thromboembolism from a European country. • We analyzed the management of these patients with a focus on advanced treatment strategies, providing estimates on the in-hospital fatality rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.